These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 1386093)

  • 1. Expression, molecular association, and functions of C3 complement receptors CR1 (CD35) and CR2 (CD21) on the human T cell line HPB-ALL.
    Delibrias CC; Fischer E; Bismuth G; Kazatchkine MD
    J Immunol; 1992 Aug; 149(3):768-74. PubMed ID: 1386093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes.
    Fischer E; Delibrias C; Kazatchkine MD
    J Immunol; 1991 Feb; 146(3):865-9. PubMed ID: 1703182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of the stimulation of complement receptors CR1 (CD35) and CR2 (CD21) on cell proliferation and intracellular Ca2+ mobilization of chronic lymphocytic leukemia B cells.
    Hivroz C; Fischer E; Kazatchkine MD; Grillot-Courvalin C
    J Immunol; 1991 Mar; 146(6):1766-72. PubMed ID: 1826011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiencies of human C3 complement receptors type 1 (CR1, CD35) and type 2 (CR2, CD21).
    Kazatchkine MD; Fearon DT
    Immunodefic Rev; 1990; 2(1):17-41. PubMed ID: 2164822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CR2 ligands modulate human B cell activation.
    Bohnsack JF; Cooper NR
    J Immunol; 1988 Oct; 141(8):2569-76. PubMed ID: 2459218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CR1(CD35) and CR2(CD21) complement C3 receptors are expressed on normal human thymocytes and mediate infection of thymocytes with opsonized human immunodeficiency virus.
    Delibrias CC; Mouhoub A; Fischer E; Kazatchkine MD
    Eur J Immunol; 1994 Nov; 24(11):2784-8. PubMed ID: 7957570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and signalling functions of C3 receptors on human B cells.
    Frade R
    Semin Immunol; 1990 Mar; 2(2):159-64. PubMed ID: 2151800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of epitope expression and the functional repertoire of recombinant complement receptor 2 (CR2/CD21) in mouse and human cells.
    Carel JC; Frazier B; Ley TJ; Holers VM
    J Immunol; 1989 Aug; 143(3):923-30. PubMed ID: 2473114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) cooperate in the binding of hydrolyzed complement factor 3 (C3i) to human B lymphocytes.
    Leslie RG; Prodinger WM; Nielsen CH
    Eur J Immunol; 2003 Dec; 33(12):3311-21. PubMed ID: 14635039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human lymphocytes shed a soluble form of CD21 (the C3dg/Epstein-Barr virus receptor, CR2) that binds iC3b and CD23.
    Frémeaux-Bacchi V; Bernard I; Maillet F; Mani JC; Fontaine M; Bonnefoy JY; Kazatchkine MD; Fischer E
    Eur J Immunol; 1996 Jul; 26(7):1497-503. PubMed ID: 8766552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligation of the functional domain of complement receptor type 2 (CR2, CD21) is relevant for complex formation in T cell lines.
    Prodinger WM; Larcher C; Schwendinger M; Dierich MP
    J Immunol; 1996 Apr; 156(7):2580-4. PubMed ID: 8786322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of C3 and C3dg to the CR2 complement receptor induces growth of an Epstein-Barr virus-positive human B cell line.
    Hatzfeld A; Fischer E; Levesque JP; Perrin R; Hatzfeld J; Kazatchkine MD
    J Immunol; 1988 Jan; 140(1):170-5. PubMed ID: 2826586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. gp140, a C3b-binding membrane component of lymphocytes, is the B cell C3dg/C3d receptor (CR2) and is distinct from the neutrophil C3dg receptor (CR4).
    Frade R; Myones BL; Barel M; Krikorian L; Charriaut C; Ross GD
    Eur J Immunol; 1985 Dec; 15(12):1192-7. PubMed ID: 3878789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of iC3b with recombinant isotypic and chimeric forms of CR2.
    Kalli KR; Ahearn JM; Fearon DT
    J Immunol; 1991 Jul; 147(2):590-4. PubMed ID: 1830068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement opsonization is required for presentation of immune complexes by resting peripheral blood B cells.
    Boackle SA; Morris MA; Holers VM; Karp DR
    J Immunol; 1998 Dec; 161(12):6537-43. PubMed ID: 9862679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct epitopes on the T cell antigen receptor of HPB-ALL tumor cells identified by monoclonal antibodies.
    Lanier LL; Ruitenberg JJ; Allison JP; Weiss A
    J Immunol; 1986 Oct; 137(7):2286-92. PubMed ID: 2428866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies to the human C3b/C4b receptor (CR1) enhance specific B cell differentiation.
    Weiss L; Delfraissy JF; Vazquez A; Wallon C; Galanaud P; Kazatchkine MD
    J Immunol; 1987 May; 138(9):2988-93. PubMed ID: 2952731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of signaling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV.
    Luxembourg AT; Cooper NR
    J Immunol; 1994 Nov; 153(10):4448-57. PubMed ID: 7525704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monovalent ligands of complement receptor 2 inhibit whereas polyvalent ligands enhance anti-Ig-induced human B cell intracytoplasmic free calcium concentration.
    Tsokos GC; Lambris JD; Finkelman FD; Anastassiou ED; June CH
    J Immunol; 1990 Mar; 144(5):1640-5. PubMed ID: 2137840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human complement receptor type 2 (CR2/CD21) transgenic mice provide an in vivo model to study immunoregulatory effects of receptor antagonists.
    Kulik L; Chen K; Huber BT; Holers VM
    Mol Immunol; 2011 Mar; 48(6-7):883-94. PubMed ID: 21269698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.